An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals
Denosumab Does Not Stimulate Early Bone Formation
Reuters Staff |
Eli Lilly and Company, which manufactures teriparatide, sponsored the trial, employed five of the 15 authors, and had various relationships with all but one of the others.
Dr. Dempster did not respond to a request for comments.